Iovance Biotherapeutics
- Market cap
- 5.85B
- P/E (TTM)i
- -18.72
- P/Bi
- 7.95
- EPSi
- -1.09
- Div yieldi
- 0.00%
- 52W posi
- 82%
Anonymous reader poll. Unscientific, not investment advice.
Iovance Biotherapeutics last traded at 12.92, down 0.35% on the session. That leaves the company valued at approximately 5.85B, the #1864 most valuable US-listed company we track. Wall Street's 7-analyst consensus lands on Buy, with a price target averaging 14.71 (+14% from here). Over the past year the stock has ranged from 1.76 to 15.30; it now sits 82% up that band.
✦ StockVane Quant Insights how this is computed
- In the model portfolio — top-12 twelve-month momentum, trading above its 200-day average.
- Signal has read STRONG BUY for 1 week.
- Its last 6 Buy calls have averaged +20% over the following quarter.
- Recent price momentum is +344.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 19.2% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 12.96
- Open
- 12.52
- Day range
- 12.31 - 13.15
- Avg price
- 12.86
- Volume
- 14.53M
- Turnover
- 186.93M
- Turnover ratei
- 3.69%
- Volume ratioi
- 0.83
- Amplitudei
- 6.47%
- 52-week rangei
- 1.76 - 15.30
Valuation
- P/Ei
- -11.85
- P/E (TTM)i
- -18.72
- P/Bi
- 7.95
- EPSi
- -1.09
- Book value / shi
- 1.63
- Net profit
- -493.74M
- Net assets
- 736.08M
Share structure
- Market cap
- 5.85B
- Float capi
- 5.09B
- Shares out
- 452.97M
- Float sharesi
- 394.31M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
15.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-36.69M net over the window
Short interest
- Shares short
- 87.13M
- % of floati
- 19.23%
- Days to coveri
- 7.43
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Iovance Biotherapeutics (IOVA)?
Iovance Biotherapeutics last traded at 12.92. The quote on this page refreshes every few seconds while US markets are open.
What is Iovance Biotherapeutics's market cap?
About 5.85B.
What is the P/E ratio of Iovance Biotherapeutics?
The trailing twelve-month P/E is -18.72. The Valuation tab shows it against the stock's own five-year range.
Does Iovance Biotherapeutics pay a dividend?
Iovance Biotherapeutics does not currently pay a regular dividend.
Is Iovance Biotherapeutics a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 14.71, which implies 13.9% upside from the current price. This is not investment advice.
What is Iovance Biotherapeutics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Iovance Biotherapeutics a A (Strong Buy). In the model portfolio — top-12 twelve-month momentum, trading above its 200-day average. Not investment advice.
Quote time 2026-10-08 07:39:53 · For reference only, not investment advice and not tailored to your situation.